Product
T-1101
Aliases
T-1101 (Tosylate)
3 clinical trials
1 indication
Indication
advanced refractory solid tumorsClinical trial
A Phase I Study of Safety, Tolerability and Pharmacokinetics of T-1101 (Tosylate) Capsules in Subjects With Advanced Refractory Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-07-31
Clinical trial
An Extension Study of T-1101 (Tosylate) Administered Orally to Patients With Advanced Refractory Solid TumorsStatus: Completed, Estimated PCD: 2019-06-24
Clinical trial
A Phase I Safety and Tolerability Study of T-1101 (Tosylate) as a Oral Powder for Constitution (OPC) in Patients With Advanced Refractory Solid TumorsStatus: Terminated, Estimated PCD: 2019-10-01